Brucke Financial, Inc.
Source: SEC Form 13F · as of Mar 2026Brucke Financial, Inc. holds 15 biotech & pharma companies tracked by BioSniper, totaling $6.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$6.6M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 1,218 | $1.1M |
| JNJJOHNSON & JOHNSON | 4,201 | $1.0M |
| NVSNovartis AG | 4,544 | $694K |
| MRKMerck & Co., Inc. | 5,675 | $683K |
| ABBVAbbVie Inc. | 2,583 | $562K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,334 | $361K |
| GILDGILEAD SCIENCES, INC. | 2,508 | $350K |
| GMEDGlobus Medical Inc. | 3,817 | $329K |
| MMSIMerit Medical Systems Inc. | 3,858 | $266K |
| ABTABBOTT LABORATORIES | 2,073 | $213K |
| INSMINSMED Inc | 1,253 | $205K |
| AZNASTRAZENECA PLC | 1,038 | $205K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,648 | $201K |
| GMOptec International, Inc. | 2,699 | $201K |
| FOLDAMICUS THERAPEUTICS, INC. | 10,567 | $153K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.